Vimarsana
Biggest News Aggregation in the World

Sanjay Murdeshwar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanjay Murdeshwar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanjay Murdeshwar Today - Breaking & Trending Today

Novartis AG announces strategic review of Novartis India - Vimarsana News

Novartis AG announces strategic review of Novartis India

Novartis India, a listed entiry, is set to undergo an assessment encompassing various aspects, including its parent Novartis AG's 70.68 percent shareholding.

Meet man who led Rs 2318 crore pharma company, resigned as MD to pursue... - Vimarsana News

Meet man who led Rs 2318 crore pharma company, resigned as MD to pursue...

He has more than 20 years of experience in the healthcare industry.

Novartis India: Novartis India MD Sanjay Murdeshwar resigns - Vimarsana News

Novartis India: Novartis India MD Sanjay Murdeshwar resigns

Sanjay Murdeshwar, the Vice Chairman and Managing Director of Novartis India, has resigned from his position. The board of Novartis India has accepted his resignation, effective from close of business hours on April 2, 2024. Murdeshwar cited the evolution of his personal and professional aspirations as the reason for his resignation.

Novartis to cut up to 8,000 jobs globally as it restructures business - Vimarsana News

Novartis to cut up to 8,000 jobs globally as it restructures business

Novartis to cut up to 8,000 jobs globally as it restructures business

Novartis Deal with Dr Reddy's Reflects Chronic Poor Governance and Shortchanging Indian Shareholders - Vimarsana News

Novartis Deal with Dr Reddy's Reflects Chronic Poor Governance and Shortchanging Indian Shareholders

Novartis India Ltd announced that it would transfer the sales and distribution of its products to Dr Reddy’s Laboratories for a few of its established medicines, including the Voveran range, the Calcium range and Methergine.